Heart Failure Pharmacology
Sort by:
Cedars Sinai
Debate: Role of Digoxin in Heart Failure and Atrial Fibrillation - in Defense of Digoxin
FEATURING
John Mandrola
- 1,887 views
- February 8, 2022
- 15
ACC 2023 Conference Coverage
ACC 2023: Beyond the Guidelines - Emerging Pharmacologic Therapies for the Heart Failure Treatment
FEATURING
Freny Mody
- 1,868 views
- April 25, 2023
- 12
Cardiology Fiesta 2018
Heart Failure and Atrial Fibrillation – What Is the Right Approach for Your Patient?
FEATURING
Jayasree Pillarisetti
- 1,857 views
- November 28, 2018
- 12
American College of Cardiology
Voyager PAD Trial: How Effective Is Rivaroxaban for Patients with Lower Extremity PAD Undergoing Revascularization?
FEATURING
Peter Block,
Deepak Bhatt
- 1,852 views
- October 22, 2020
- 6
Northwestern Medicine Cardiovascular Care
15th Annual Heart Failure Holiday Symposium: Highlights and Takeaways
- 1,790 views
- January 3, 2020
- 16
Cedars Sinai
SGLT2 Inhibitors: Are They the Modern-Day Statins? Insights from Recent Cardiorenal Metabolic Outcome Trial
FEATURING
Sanjay Kaul,
Milton Packer
- 1,785 views
- February 7, 2022
- 9
American Heart & Vascular Institute
Heart Failure With Preserved Ejection Fraction: Is the New Paradigm Treatment Finally Here? Insights from the EMPEROR-Preserved Trial
FEATURING
Javed Butler
- 1,739 views
- September 9, 2021
- 12
Piedmont Heart Institute
Cardiometabolic Therapies: GLP-1 RAs and SGLT-2i
FEATURING
Jaime Burkle
- 1,738 views
- January 25, 2022
- 18
AHA 2023 Insights
AHA 2023 Insights: Optimizing the Use of SGLT2is, GLP-1 RAs and Non-Steroidal MRAs for Multi-System Benefit
FEATURING
Faiez Zannad
- 1,706 views
- November 21, 2023
- 19
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Advances in Temporary Mechanical Support for Acute Heart Failure: What Pharmacological Agents Do We Have and What Are Their Detrimental Effects? When to Use IABP, Impella, Tandem Heart and ECMO?
FEATURING
Ryan Reeves
- 1,701 views
- February 8, 2021
- 12
AHA 2022 Conference Coverage
AHA 2022: Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction
FEATURING
Pieter Martens
- 1,700 views
- November 14, 2022
- 11
Canadian Collaborative Research Network
HFpEF: Which Drugs Have Become Standard Care?
FEATURING
Milan Gupta
- 1,695 views
- June 13, 2022
- 12
The Texas Heart Institute
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
FEATURING
Biykem Bozkurt
- 1,678 views
- February 8, 2023
- 19
Canadian Collaborative Research Network
Myocarditis Associated with COVID-19 Infection and Vaccines
FEATURING
Michael Chetrit
- 1,647 views
- August 31, 2022
- 7
CCM® Therapy
Virtual EP Connect Highlights: Revisiting CCM Therapy: Who Are the Right Patients?
FEATURING
Vivek Reddy,
Rahul N. Doshi,
Francis Marchlinski,
Jürgen Kuschyk,
William Abraham,
Anuradha Lala-Trindade
- 1,637 views
- October 17, 2023
- 7
Mount Sinai Advanced Heart Symposium 2016
Chronic Heart Failure Update: Incorporating Sacubatril / Valsartan and Ivabradine into Clinical Practice
FEATURING
Sean Pinney
- 1,622 views
- February 14, 2017
- 14
ACC 2024 Insights
ACC 2024 Insights: Stop the Meds! Treat the Comorbidities for Optimal Outcomes
FEATURING
Kim Williams
- 1,573 views
- April 26, 2024
- 13
Houston Methodist DeBakey Heart and Vascular Center
Tips and Tricks for Medical Optimization of HF in the Clinic
FEATURING
Ashrith Guha
- 1,570 views
- March 5, 2022
- 6
Canadian Collaborative Research Network
Chronic Kidney Disease: New Treatments to Improve Outcomes
FEATURING
Louise Moist
- 1,527 views
- July 26, 2023
- 10